3/11/2024 | CV | Tandem greenshoe exercised, ups convertibles to $316.25 million
|
3/8/2024 | CV | Market Commentary: Convertibles see $5.95 billion of issuance for week; Tandem gains continue; Rivian rises
|
3/8/2024 | CV | Market Commentary: Morning Commentary: Convertibles primary marks historic week of issuance; Tandem rises
|
3/7/2024 | CV | Market Commentary: Xerox convertibles struggle on debut; Avid Bioservices prices overnight; Tandem surges
|
3/6/2024 | CV | Market Commentary: Xerox convertibles eyed; $4.38 billion in supply hits aftermarket, strong on debut
|
3/6/2024 | CVLM | Tandem negotiates repurchase of $246.7 million convertibles due 2025
|
3/6/2024 | CV | Market Commentary: Morning Commentary: Xerox convertibles eyed; $4.38 billion in supply hits aftermarket
|
3/6/2024 | CV | New Issue: Tandem Diabetes sells upsized $275 million five-year convertibles at 1.5%, up 27.5%
|
3/5/2024 | CV | Market Commentary: Xerox convertibles join calendar; primary to price $3.95 billion in six deals post-close
|
3/5/2024 | CV | Market Commentary: Morning Commentary: Convertibles primary to price $3.95 billion in six deals post-close
|
3/4/2024 | CV | Market Commentary: Convertibles primary launches $4.15 billion in seven deals; iRhythm, MP Materials eyed
|
3/4/2024 | CV | Tandem Diabetes talks $250 million five-year convertibles to yield 1.25%-1.75%, up 25%-30%
|
12/12/2023 | SP | New Issue: RBC prices $889,000 notes linked to 22 Raymond James securities selections
|
12/11/2023 | SP | New Issue: RBC prices $470,000 notes linked to 22 Raymond James securities selections
|
8/8/2023 | SP | New Issue: Barclays sells $613,000 autocallable contingent coupon notes on Tandem Diabetes
|
4/29/2022 | SP | New Issue: GS Finance sells $9.25 million basket-linked notes tied to 77 stocks
|
2/22/2022 | SP | New Issue: JPMorgan sells $2.22 million contingent interest autocalls on Tandem Diabetes Care
|
12/6/2021 | SP | New Issue: BofA prices $4.4 million contingent income autocallable yield notes on Tandem
|
12/6/2021 | SP | New Issue: BofA sells $2 million contingent income autocalls on DexCom and Tandem
|
8/26/2021 | SP | New Issue: GS Finance prices $13.14 million leveraged basket-linked notes on 179 stocks
|
12/24/2020 | SP | New Issue: Credit Suisse sells $800,000 contingent coupon autocallable reverse converts on Tandem
|
5/15/2020 | CV | Tandem Diabetes greenshoe lifts 1.5% convertibles to $287.5 million
|
5/13/2020 | CV | Market Commentary: Plug Power, Veeco eyed; $2.04 billion of paper floods secondary; most trades below par
|
5/13/2020 | CV | Market Commentary: Morning Commentary: Plug Power, Veeco on tap; $2.04 billion of paper floods secondary
|
5/13/2020 | CV | New Issue: Tandem Diabetes Care prices $250 million five-year convertibles at 1.5%, up 30%
|
5/12/2020 | CV | Market Commentary: Convertibles primary set to price $2.05 billion in five deals; new notes flood secondary
|
5/12/2020 | CV | Tandem Diabetes talks $250 million five-year convertibles to yield 1%-1.5%, up 30%-35%
|
5/31/2019 | SP | Goldman amends Cusip for notes tied to basket of Russell 3000 stocks
|
5/9/2019 | SP | New Issue: Goldman sells $1 million notes tied to basket of Russell 3000 stocks
|
4/8/2019 | SP | New Issue: Credit Suisse sells $800,000 contingent coupon autocall reverse converts on Tandem Diabetes
|
8/8/2018 | BKPV | Tandem Diabetes Care fully repays term loan via Capital Royalty
|
11/29/2016 | PV | Tandem Diabetes draws $35 million more under Capital Royalty term loan
|
1/12/2016 | PV | Tandem Diabetes amends loan agreement to access additional $50 million
|
3/4/2015 | PP | Tandem Diabetes Care greenshoe exercise increases IPO to $69.4 million
|
2/27/2015 | PP | Tandem Diabetes prices $60.38 million public sale of stock at $11.50
|
2/24/2015 | PP | Tandem Diabetes plans $60 million public offering of common stock
|